Norgine Announces Appointment of New CEO Janneke van der Kamp
Norgine (the "Company"), a leading European specialty pharmaceutical company, has today announced the appointment of Janneke van der Kamp as its new Chief Executive Officer (CEO), effective from 1 January 2025. Current CEO, Chris Bath, has stepped down from his role effective immediately.
This change in leadership will support and enhance the Companys mission of bringing transformative medicines to patients and consumers. It will further enable Norgines strong growth trajectory, focused on advancing existing brands,!-->…